UTHR in the 13F filings
United Therapeutics Corp Del · CUSIP 91307C102
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 24 May 2024
- latest of these filings; the earliest 10 May 2024
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 10 listed it in both
- Shares listed
- 9,498,146
- combined, among listed positions
- Reported value
- $2.2bn
- combined, at the quarter end
Among the 93 comparable managers: 14 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing UTHR in Q1 2024
19 of 19 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 846,955 shares now+295,188
- Point72 Asset Management LPnew position · 162,700 shares now+162,700
- Acadian Asset Management LLCexisting position · 111,956 shares now+80,478
- Two Sigma Investments LPexisting position · 141,086 shares now+51,507
- Hudson Bay Capital Management LPexisting position · 20,000 shares now+8,900
Reductions
- Wellington Management Group LLPexisting position · 3,412,260 shares now-381,750
- Farallon Capital Management LLCexisting position · 110,000 shares now-366,000
- Janus Henderson Group Ltdexisting position · 635,347 shares now-234,772
- Renaissance Technologies LLCexisting position · 2,151,714 shares now-18,500
- PDT Partners LLCexisting position · 5,840 shares now-3,607
New positions and exits
New (2)
Exited (1)
- Caxton Associates LLPwas $6.6m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 5 | $378m | n.a. | n.a. |
| Q3 2013 | 5 | $587m | n.a. | n.a. |
| Q4 2013 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2014 | 8 | $923m | n.a. | n.a. |
| Q2 2014 | 9 | $716m | n.a. | n.a. |
| Q3 2014 | 11 | $1.1bn | n.a. | n.a. |
| Q4 2014 | 10 | $1.2bn | n.a. | n.a. |
| Q1 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q2 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q3 2015 | 16 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 17 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 12 | $869m | n.a. | n.a. |
| Q3 2016 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2016 | 10 | $1.1bn | n.a. | n.a. |
| Q1 2017 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.2bn | n.a. | n.a. |
| Q3 2017 | 8 | $1.1bn | n.a. | n.a. |
| Q4 2017 | 10 | $1.4bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2018 | 10 | $996m | n.a. | n.a. |
| Q3 2018 | 9 | $1.1bn | n.a. | n.a. |
| Q4 2018 | 9 | $1.0bn | n.a. | n.a. |
| Q1 2019 | 9 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 15 | $804m | n.a. | n.a. |
| Q3 2019 | 17 | $913m | n.a. | n.a. |
| Q4 2019 | 14 | $863m | n.a. | n.a. |
| Q1 2020 | 14 | $1.2bn | n.a. | n.a. |
| Q2 2020 | 14 | $1.4bn | n.a. | n.a. |
| Q3 2020 | 10 | $797m | n.a. | n.a. |
| Q4 2020 | 11 | $1.2bn | n.a. | n.a. |
| Q1 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 16 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 14 | $1.7bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.3bn | n.a. | n.a. |
| Q3 2022 | 17 | $2.2bn | n.a. | n.a. |
| Q4 2022 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2023 | 16 | $2.5bn | n.a. | n.a. |
| Q2 2023 | 12 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 13 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.3bn | 8 | 6 |
| Q1 2024 | 19 | $2.2bn | 14 | 6 |
| Q2 2024 | 14 | $2.5bn | 8 | 7 |
| Q3 2024 | 10 | $2.9bn | 6 | 4 |
| Q4 2024 | 14 | $3.3bn | 8 | 4 |
| Q1 2025 | 14 | $2.1bn | 7 | 6 |
| Q2 2025 | 14 | $1.9bn | 9 | 5 |
| Q3 2025 | 16 | $2.6bn | 8 | 10 |
| Q4 2025 | 14 | $3.8bn | 17 | 20 |
| Q1 2026 | 18 | $5.1bn | 18 | 17 |
| Q2 2026 | 14 | $3.5bn | 19 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own UTHR, latest filings →Back to the 13F Explorer →